Smoking cessation may deteriorate glycemic control in diabetic patients
the ONA take:
Patients with type 2 diabetes mellitus who quit smoking see a temporary deterioration in glycemic control that may last up to three years, according to a recent study published in The Lancet Diabetes & Endocrinology.
Researchers led by Deborah Lycett, PhD, of Convetry University studied primary care records of 10,692 adult smokers with type 2 diabetes mellitus over six years to see if there was any association between diabetes control and smoking cessation.
They found that in 3,131 people (29 percent) who had quit for at least one year, HbA1c increased by 2.3 mmol/mol before gradually decreasing as abstinence continued.
During the same amount of time, 5,831 (55 percent) of patients who continually smoked experienced a more gradual increase in HbA1c. Those who quit saw comparable HbA1c levels with continual smokers after three years of quitting.
“Knowing that deterioration in blood glucose control occurs around the time of stopping smoking helps to prepare those with diabetes and their clinicians to be proactive in tightening their glycemic control during this time,” Dr. Lycett concluded.
Patients with type 2 diabetes mellitus who quit smoking see a temporary deterioration in glycemic control that may last up to three years.
Sign Up for Free e-newsletters
- Avoiding the ED: Planned Strategies for Unplanned Urgent Cancer Care
- NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
- Art as Palliative Care: Bedside Intervention Improves Pain, Anxiety, Mood in Hospitalized Cancer Patients
- Unprotected Sex After Chemotherapy
- Mindfulness Training May Improve End-of-Life Conversations in Advanced Cancer
- Prognostic Factors for Survival Among Patients With Primary Bone Sarcomas of Small Bones
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- A Call for More Tailored Cancer Education Programs to Improve Screening
- Aligning Patient Goals With End of Life Treatment Decisions
- Study Suggests Greater Focus on the Needs of Family Caregivers of Patients With Cancer
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|